Keywords: cash, shortages, lead, decline, biotech, licensing, mega-deals

Cash shortages lead to decline of biotech licensing mega-deals, says Lehman report

Article | 01 September 2008

Print This

While licensing deals are still key drivers for the biotechnology sector, growth has stalled in the average value of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in